Natural Product: NPC320369

Natural Product IDNPC320369
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
SHDCXMVFGZHYMZ-UHFFFAOYSA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID 54305395
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000175] Glycerolipids
        • [CHEMONTID:0003815] Triradylcglycerols
          • [CHEMONTID:0001135] Triacylglycerols

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey SHDCXMVFGZHYMZ-UHFFFAOYSA-N
Standard InCHI InChI=1S/C99H194O6/c1-4-7-10-13-16-19-22-25-28-31-34-37-40-43-46-49-52-55-58-61-64-67-70-73-76-79-82-85-88-91-97(100)103-94-96(105-99(102)93-90-87-84-81-78-75-72-69-66-63-60-57-54-51-48-45-42-39-36-33-30-27-24-21-18-15-12-9-6-3)95-104-98(101)92-89-86-83-80-77-74-71-68-65-62-59-56-53-50-47-44-41-38-35-32-29-26-23-20-17-14-11-8-5-2/h96H,4-95H2,1-3H3
SMILES CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   1479.49 Volume:   1765.691
?
Van der Waals volume.
Dense:   0.838 LogP:   13.172
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   6.883
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -12.09
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   98.0 Rigid Bonds:   3.0
TPSA:   78.9
?
Topological Polar Surface Area.
H-Bond Acceptor:   6.0
H-Bond Donor:   0.0 Rings:   0.0
Heavy Atoms:   6.0

MedChem Properties

QED Drug-Likeness Score:   0.034 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   3.884 Fsp3:   0.97
MCE-18:   0.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.665 Fluc inhibitor:   0.331
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.0
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.0
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.924 Promiscuous compounds:   0.331

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.302 MDCK Permeability:   -5.5
Pgp-inhibitor:   0.0 Pgp-substrate:   0.0
PAMPA:   0.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   1.0
20% Bioavailability (F20%):   1.0 30% Bioavailability (F30%):   1.0
50% Bioavailability (F50%):   1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   1.0
Plasma Protein Binding (PPB):   121.627% Volume Distribution (VD):   7.938
Fu: 0.0%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.02
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   1.0
BSEP inhibitor:   1.0

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   1.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   1.0
CYP2C9-inhibitor:   0.006 CYP2C9-substrate:   1.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   1.0
CYP3A4-inhibitor:   0.006 CYP3A4-substrate:   1.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   1.0
HLM stability:   0.003
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  3.078 Half-life (T1/2):  20.225

ADMET: Toxicity

hERG Blockers:  1.0 hERG Blockers (10um):  1.0
Human Hepatotoxicity (H-HT):  0.59 Drug-induced Liver Injury (DILI):  0.121
AMES Toxicity:  0.0 Rat Oral Acute Toxicity:  0.002
Maximum Recommended Daily Dose:  0.489 Skin Sensitization:  1.0
Carcinogencity:  0.118 Eye Corrosion:  0.109
Eye Irritation:  0.73 Respiratory Toxicity:  1.0
Drug-induced Neurotoxicity:  0.0 Ototoxicity:  0.032
Hematotoxicity:  0.005 Drug-induced Nephrotoxicity:  0.078
Genotoxicity:  0.0 RPMI-8226 Immunitoxicity:  0.056
A549 Cytotoxicity:  1.0 Hek293 Cytotoxicity:  0.859
BCF:   -5.604
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   7.541
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   10.989
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   5.438
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO14406 Anser cygnoides Species Anatidae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO14406 Anser cygnoides Species Anatidae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO31199 Jnula britannica n.a. n.a. n.a. n.a. n.a. n.a. Database[TCM_Taiwan]
NPO14406 Anser cygnoides Species Anatidae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO14406 Anser cygnoides Species Anatidae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC320369 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC55678
0.7647 Intermediate Similarity NPC602940
0.75 Intermediate Similarity NPC54925
0.6429 Remote Similarity NPC224700
0.6429 Remote Similarity NPC320663
0.6207 Remote Similarity NPC47363
0.6207 Remote Similarity NPC250028
0.6207 Remote Similarity NPC236579
0.6207 Remote Similarity NPC80234
0.6207 Remote Similarity NPC287231
0.6207 Remote Similarity NPC203531
0.6207 Remote Similarity NPC256163
0.6207 Remote Similarity NPC40597
0.587 Remote Similarity NPC488690
0.5806 Remote Similarity NPC603863
0.5625 Remote Similarity NPC603612
0.561 Remote Similarity NPC48218
0.561 Remote Similarity NPC141481
0.561 Remote Similarity NPC464342
0.5588 Remote Similarity NPC488257
0.5588 Remote Similarity NPC469937
0.5588 Remote Similarity NPC94699
0.5588 Remote Similarity NPC320588
0.5588 Remote Similarity NPC53463
0.5517 Remote Similarity NPC53541
0.551 Remote Similarity NPC83839
0.5455 Remote Similarity NPC149299
0.5455 Remote Similarity NPC310746
0.5294 Remote Similarity NPC26253
0.5294 Remote Similarity NPC489083
0.5294 Remote Similarity NPC23155
0.5227 Remote Similarity NPC473559
0.5227 Remote Similarity NPC324981
0.5192 Remote Similarity NPC488693
0.5192 Remote Similarity NPC488689
0.5161 Remote Similarity NPC63182
0.5161 Remote Similarity NPC145045
0.5161 Remote Similarity NPC52700
0.5152 Remote Similarity NPC80396
0.5152 Remote Similarity NPC154642
0.5152 Remote Similarity NPC600941
0.5143 Remote Similarity NPC128061
0.5094 Remote Similarity NPC331437

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC320369 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
1.0 High Similarity NPD6125 Phase 4
0.6571 Remote Similarity NPD3730 Pre-clinical
0.6429 Remote Similarity NPD8278 Phase 4
0.6207 Remote Similarity NPD2699 Pre-clinical
0.6 Remote Similarity NPD8277 Approved
0.575 Remote Similarity NPD3728 Approved
0.551 Remote Similarity NPD8304 Clinical (unspecified phase)

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data